Clinical and neuroradiological improvement in chronic acquired hepatocerebral degeneration after branched-chain amino acid therapy
Authors:
- 27 June 2002
- journal article
- case report
- Published by Hindawi Limited in Acta Neurologica Scandinavica
- Vol. 106 (2) , 113-116
Abstract
We report two patients with chronic acquired hepatocerebral degeneration (CAHD) who showed neurological and radiological improvement after the administration of branched‐chain amino acids (BAA). The first patient with chronic hepatitis C presented with progressive parkinsonism for 7 months, whereas the second patient with liver cirrhosis presented with progressive ataxia for 15 months. T1‐weighted magnetic resonance imaging (MRI) showed symmetric high intensity signals in the lenticular nuclei in both patients. In the first patient, single photon emission computed tomography (SPECT) disclosed a marked decrease in cerebral blood flow in the parieto‐occipital regions. In the second patient, T2‐weighted MRI demonstrated symmetric high intensity signals in the deep cerebral and cerebellar white matter. After the administration of BAA, their neurological signs and radiological abnormalities markedly improved in both patients. CAHD might be a reversible and treatable disorder where aromatic amino acids are deeply involved in its pathogenesis.Keywords
This publication has 12 references indexed in Scilit:
- Decrease of regional cerebral blood flow in liver cirrhosisEuropean Journal of Gastroenterology & Hepatology, 2000
- Portal Systemic Encephalopathy Presenting with Dressing and Constructional Apraxia.Internal Medicine, 2000
- Expedited PublicationNeurology, 1996
- Chronic acquired hepatocerebral degeneration: Case reports and new insightsMovement Disorders, 1995
- Brain SPECT Imaging With Tc-99m HMPAO in Hepatic EncephalopathyClinical Nuclear Medicine, 1995
- SPECT scan and cognitive findings in subclinical hepatic encephalopathy [published erratum appears in J Neuropsychiatry Clin Neurosci 1994 Fall;6(4):492]The Journal of Neuropsychiatry and Clinical Neurosciences, 1994
- Portal-systemic encephalopathy: presence of basal ganglia lesions with high signal intensity on MR images.Radiology, 1991
- DISTRIBUTION OF CEREBRAL LESIONS IN ACQUIRED HEPATOCEREBRAL DEGENERATIONBrain, 1981
- FALSE NEUROTRANSMITTERS AND HEPATIC FAILUREThe Lancet, 1971
- THE ACQUIRED (NON-WILSONIAN) TYPE OF CHRONIC HEPATOCEREBRAL DEGENERATIONMedicine, 1965